| Immunotherapy at any line of treatment improves survival in patients with advanced metastatic Non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) Thoracic Cancer, 1-9, 2019 | 44* | 2019 |
| Application of artificial intelligence in pharmaceutical and biomedical studies A Thakur, AP Mishra, B Panda, D Rodríguez, I Gaurav, B Majhi Current pharmaceutical design 26 (29), 3569-3578, 2020 | 36 | 2020 |
| Mortality and advanced support requirement for patients with cancer with COVID-19: a mathematical dynamic model for Latin America A Ruiz-Patiño, O Arrieta, LE Pino, C Rolfo, L Ricaurte, G Recondo, ... JCO global oncology 6, 752-760, 2020 | 16 | 2020 |
| PANDEMIAS, INFORMACIÓN Y MEDIOS: COVID-19, UN EJEMPLO A TRAVÉS DE LA CRISIS. DC Sotelo Rodríguez Medicina 42 (2), 143-146., 2020 | 15 | 2020 |
| Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries. L Cardona, A. F., Arrieta, O., Ruiz-Patiño, A., Sotelo, C., Zamudio-Molano ... Therapeutic Advances in Respiratory Disease 14, 2020 | 14 | 2020 |
| Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP) Thoracic Cancer, 1 - 9, 2020 | 12* | 2020 |
| Case report: differential genomics and evolution of a meningeal melanoma treated with ipilimumab and nivolumab R Burgos, AF Cardona, N Santoyo, A Ruiz-Patiño, J Cure-Casilimas, ... Frontiers in Oncology 11, 691017, 2022 | 6 | 2022 |
| Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies DC Sotelo-Rodríguez, A Ruíz-Patiño, L Ricaurte, O Arrieta, ... ecancermedicalscience 13, 2019 | 5 | 2019 |
| Human papillomavirus infection in metastatic lung adenocarcinoma is associated with better outcomes with immune checkpoint inhibitor treatment. LL Rojas Puentes, A Ruiz-Patiño, DC Mayorga Gonzalez, JK Rodríguez, ... Journal of Clinical Oncology 38 (15_suppl), e21569-e21569, 2020 | 1 | 2020 |
| Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors 2 Carolina Sotelo-Rodr´ ıguez, MD1, 2 Dora Vallejo-Ardila, MBBS, PhD1, ... JCO Global Oncology 10 (10), 1 - 12, 2024 | | 2024 |
| Mecanismos de resistencia a osimertinib de primera línea en pacientes hispanos con cáncer de pulmón de células no pequeñas mutante en EGFR AFC Zorrilla, AR Patiño, DCS Rodríguez, NDS Sarmiento, SAM Espinosa, ... Revista Colombiana de Hematología y Oncología 9 (Supl), 228-229, 2022 | | 2022 |
| RESEÑA HISTÓRICA DE LAS INSTITUCIONES QUE CAMBIARON EL CURSO DE LA HISTORIA DEL CÁNCER (MSKCC, NCI, MDACC, GUSTAVE ROUSSY, NCI) SRDC a Revista Medicina 42 (4), 632 - 639, 2021 | | 2021 |
| Histopathological prognostic markers in metastatic lung adenocarcinoma, validation of stromal fibrosis and immunoscore as easy to interpret findings and their correlation with … LL Rojas Puentes, A Ruiz-Patiño, DC Mayorga, JK Rodríguez, ... Journal of Clinical Oncology 38 (15_suppl), e21566-e21566, 2020 | | 2020 |
| Reseña histórica de las instituciones que cambiaron el curso de la historia del cáncer (MSKCC, NCI, MDACC, Gustave Roussy, NCI) DCS Rodríguez Medicina 42 (4), 632-639, 2020 | | 2020 |
| Effect of immunotherapy at any line of treatment on survival in Hispanic patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy … AF Cardona Zorrilla, A Ruiz-Patiño, O Arrieta, C Martin, LE Raez, ... Journal of Clinical Oncology 37 (15_suppl), e20637-e20637, 2019 | | 2019 |
| Revista Nova et Vetera DCS Rodríguez | | |
| Requisito de mortalidad y apoyo avanzado para pacientes con cáncer con COVID-19: un modelo matemático dinámico para América Latina A Ruíz-Patiño, O Arrieta, LE Pino, C Rolfo, L Ricaurte, G Recondo, ... Elsevier Ltd, 0 | | |
| Genotyping squamous cell lung carcinoma in Colombia (Geno1. 1-CLICaP) AF Cardona-Mendoza, A Ruiz-Patinõ, O Arrieta, LM Ricaurte, ... Frontiers Media SA, 0 | | |
Alejandro Ruiz-PatiñoFoundation for Clinical and Applied Cancer ResearchVerified email at javeriana.edu.co
